Author

K. D. Rivera

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 3 Biochemistry· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 5 Assay:proteomics· 5 Organism:human· 3 Research Focus:cell type annotation· 2 Research Focus:host-pathogen & immune response· 2 Organism:mouse· 2 Research Focus:cell signaling & trafficking· 1 Research Focus:chromatin & epigenetic regulation· 1

Frequent Co-Authors

S. A. Carr· 3 shared D. A. Tuveson· 2 shared D. J. Pappin· 2 shared E. J. Bergstrom· 2 shared H. B. Taylor· 2 shared J. G. Abelin· 2 shared K. R. Clauser· 2 shared M. E. Olive· 2 shared

Activity by Year

2020-2021 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCancer Biology

S. A. Carr

Mutual co-authors in cluster

Author profile →

5 papers

Recent·Most cited

MONTE enables serial immunopeptidome, ubiquitylome, proteome, phosphoproteome, acetylome analyses of sample-limited tissues

J. G. Abelin, E. J. Bergstrom, H. B. Taylor, K. D. Rivera, S. Klaeger, C. Xu, C. J. White, M. E. Olive, M. Maynard, M. H. Kane, S. Rachimi, D. R. Mani, M. A. Gillette, K. R. Clauser, N. D. Udeshi, S. A. Carr

MONTE enables serial multi-omic analysis of immunopeptidome, ubiquitylome, proteome, phosphoproteome, and acetylome from the same tissue samples, preserving precious human material and identifying immunotherapeutic targets.

bioRxiv · Jun 22, 2021 · PreprintCancer Biology

Automating UbiFast for High-throughput and Multiplexed Ubiquitin Enrichment

K. D. Rivera, M. E. Olive, E. J. Bergstrom, A. J. Nelson, K. A. Lee, S. Satpathy, S. A. Carr, N. D. Udeshi

The paper automates the UbiFast method to enable high-throughput, multiplexed ubiquitylation profiling, identifying ~20,000 sites from 500 g input in ~2 hours with improved reproducibility and scalability.

bioRxiv · Apr 28, 2021Biochemistry

SARS-CoV-2 infected cells present HLA-I peptides from canonical and out-of-frame ORFs

S. Weingarten-Gabbay, S. Klaeger, S. Sarkizova, L. R. Pearlman, D.-Y. Chen, M. R. Bauer, H. B. Taylor, H. L. Conway, C. H. Tomkins-Tinch, Y. Finkel, A. Nachshon, M. Gentili, K. D. Rivera, D. B. Keskin, C. M. Rice, , P. C. Sabeti

The paper identifies HLA-I peptides from SARS-CoV-2 in infected cells, revealing epitopes from both canonical and out-of-frame ORFs, which could inform vaccine development.

bioRxiv · Oct 2, 2020 · PreprintImmunology

Oncogenic KRAS engages an RSK1/NF1 complex in pancreatic cancer

D. K. Cheng, T. E. Oni, Y. Park, J. S. Thalappillil, H.-c. Ting, N. Prasad, B. Alagesan, K. D. Rivera, D. J. Pappin, L. Van Aelst, D. A. Tuveson

This study identifies RSK1 as a KRASG12D-specific interactor in PDAC and shows RSK1 mediates negative feedback on wild-type KRAS.

bioRxiv · Sep 14, 2020 · PreprintCancer Biology

DETECTION OF INCIPIENT PANCREATIC CANCER WITH NOVEL TUMOR-SPECIFIC ANTIBODIES IN MOUSE MODELS

T. E. Oni, C. Bautista, J. R. Merrill, J. A. C. M. Goos, K. D. Rivera, K. Miyabayashi, G. Biffi, L. Garcia, D. Plenker, H. Patel, E. Elyada, M. Samaritano, K. H. Yu, D. J. Pappin, M. G. Goggins, , D. A. Tuveson

This study develops tumor-specific antibodies for early detection of pancreatic cancer using PET imaging in mouse models, identifying two mAbs that bind to CEACAM6 variants in tumors.

bioRxiv · Sep 10, 2020 · PreprintCancer Biology